萬邦達(300055.SZ):計提資產減值損失合計4.50億元
格隆匯1月25日丨萬邦達(300055.SZ)公佈,根據2021年1月25日公司與集寧區政府簽訂的項目回購協議書可確定,公司實施項目所涉資產可收回金額為15.54億元。項目所涉資產可收回金額低於公司賬面價值,公司需計提資產減值損失,減值金額為4.36億元。鑑於重組協議中約定的剩餘回購款3.41億元將於2021年12月31日前支付,考慮其時間價值,按同期銀行貸款利率進行折現計提減值損失0.14億元。
本次計提資產減值損失合計4.50億元,導致公司2020年度合併報表歸屬於母公司的淨利潤減少4.50億元,並相應減少公司2020年12月31日的資產淨值,對公司2020年度的經營現金流沒有影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.